SCHEMBL27056788

SCHEMBL27056788

C=CC(=O)Nc1ccc2c(c1)n(C(C)C)c(=O)n2C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ TP53 P04637 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ XIAP P98170 1/20 0.51
▸ BIRC2 Q13490 1/20 0.51
▸ HPD P32754 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ TGM2 P21980 3/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ PABPC1 P11940 1/20 0.42
▸ EIF4H Q15056 1/20 0.42
▸ NOX1 Q9Y5S8 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ BRD4 O60885 2/20 0.41
▸ BRPF1 P55201 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25735906 0.86 SMN1; SMN2 (0.68) SMN1; SMN2TP53HSD17B10XIAPBIRC2
SCHEMBL25737033 0.83 SMN1; SMN2 (0.55) SMN1; SMN2TP53HSD17B10XIAPBIRC2
SCHEMBL26280415 0.74 SMN1; SMN2 (0.47) SMN1; SMN2TP53HSD17B10XIAPBIRC2
SCHEMBL27446319 0.74 HPD (0.62) SMN1; SMN2HSD17B10HPDALDH1A1HTT
SCHEMBL27056782 0.71 PSMB8 (0.51) SMN1; SMN2TP53HSD17B10LMNATGM2
SCHEMBL24812336 0.71 HPD (0.55) SMN1; SMN2TP53HSD17B10XIAPBIRC2
SCHEMBL24130675 0.70 HPD (0.41) SMN1; SMN2TP53HSD17B10XIAPBIRC2
SCHEMBL27300521 0.70 HPD (0.50) SMN1; SMN2HSD17B10XIAPBIRC2HPD
SCHEMBL28016711 0.69 TGM2 (0.49) TP53LMNATGM2NOX1MEN1
SCHEMBL25597800 0.69 HTR2B (0.54) SMN1; SMN2TP53LMNATGM2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES THE BROAD INSTITUTE, INC. 2024-01-25 — — US disclosed
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES THE BROAD INSTITUTE, INC. 2024-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES COASY, JMJD7, PTMS SMN1; SMN2 3607/4885TP53 1216/4885HSD17B10 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback